Nociceptin/orphanin FQ acts as a functional antagonist of corticotropin-releasing factor to inhibit its anorectic effect

Physiology and Behavior

Volumn 82, Issue 1, 2004, Pages 63-68

  Ciccocioppo, Roberto ^a   Cippitelli, Andrea ^a   Economidou, Daina ^a   Fedeli, Amalia ^a   Massi, Maurizio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Bed nucleus of the stria terminalis; Corticotropin releasing factor; Corticotropin releasing factor induced anorexia; Nociceptin; NOP receptor; Orphanin FQ; Ro 64 6198

Indexed keywords

8 (2,3,3A,4,5,6 HEXAHYDRO 1H PHENALEN 1 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; ANOREXIGENIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DIAZEPAM; GLUCOCORTICOID; LIGAND; LIPOPOLYSACCHARIDE; NOCICEPTIN; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; RO 64 6918; UNCLASSIFIED DRUG;

ANOREXIA; BEHAVIOR; CELL NUCLEUS; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG TARGETING; ELECTRIC SHOCK; ESCHERICHIA COLI; EXERCISE; FEEDING; FEEDING BEHAVIOR; FOOD INTAKE; HYPERPHAGIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; STRIA TERMINALIS;

EID: 3242754992     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2004.04.035     Document Type: Article

References (53)

1. Boyar R.M., Hellman M., Roffwarg H., Katz J., Zumoff B., O'Connor J., et al. Cortisol secretion and metabolism in anorexia nervosa. N. Engl. J. Med. 296:1977;190-193
2. Calo' G., Guerrini R., Rizzi A., Salvadori S., Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129:2000;1261-1283
3. 1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350
4. Ciccocioppo R., Martin-Fardon R., Weiss F., Massi M. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. NeuroReport. 12:2001;1145-1149
5. Ciccocioppo R., Biondini M., Antonelli L., Wichmann J., Jenck F., Massi M. Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198. Psychopharmacology (Berl). 161:2002;113-119
6. Ciccocioppo R., Fedeli A., Economidou D., Policani F., Weiss F., Massi M. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J. Neurosci. 23:2003;9445-9451
7. Connan F., Campbell I.C., Katzman M., Lightman S.L., Treasure J. A neurodevelopmental model for anorexia nervosa. Physiol. Behav. 79:2003;13-24
8. Davis M., Whalen P.J. The amygdala: vigilance and emotion. Mol. Psychiatry. 6:2001;13-34
9. Dayas C.V., Buller K.M., Crane J.W., Xu Y., Day T.A. Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups. Eur. J. Neurosci. 14:2001;1143-1152
10. Dayas C.V., Day T.A. Opposing roles for medial and central amygdala in the initiation of noradrenergic cell responses to a psychological stressor. Eur. J. Neurosci. 15:2002;1712-1718
11. Devine D.P., Watson S.J., Akil H. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis. Neuroscience. 102:2001;541-553
12. Dong H.W., Petrovich G.D., Swanson L.W. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res. Rev. 38:2001;192-246
13. Erb S., Shaham Y., Stewart J. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J. Neurosci. 18:1998;5529-5536
14. Erb S., Stewart J. A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor onstress-induced reinstatement of cocaine seeking. J. Neurosci. 19:1999;RC35
15. Foppiani L., Sessarego P., Valenti S., Falivene M.R., Cuttica C.M., Giusti D.M. Lack of effect of desmopressin on ACTH and cortisol responses to ovine corticotropin-releasing hormone in anorexia nervosa. Eur. J. Clin. Invest. 26:1996;879-883
16. Griebel G., Perrault G., Sanger D.J. Orphanin FQ, a novel neuropeptide with anti-stress-like activity. Brain Res. 836:1999;221-224
17. Gwirtsman H.E., Kaye W.H., George D.T., Jimerson D.C., Ebert M.H., Gold P.W. Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia. Arch. Gen. Psychiatry. 46:1989;61-69
18. Heim C., Nemeroff C.B. The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biol. Psychiatry. 46:1999;1509-1522
19. Heinrichs S.C., Richard D. The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides. 33:1999;350-359
20. Hotta M., Shibasaki T., Arai K., Demura H. Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats. Brain Res. 823:1999;221-225
21. Hotta M., Shibasaki T., Masuda A., Imaki T., Demura H., Ling N., et al. The response of plasma corticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients. J. Clin. Endocrinol. Metab. 62:1986;319-324
22. Ikeda K., Watanabe M., Ichikawa T., Kobayashi T., Yano R., Kumanishi T. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J. Comp. Neurol. 399:1998;139-151
23. Jenck F., Moreau J.L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma F.J. Jr., et al. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U. S. A. 94:1997;14854-14858
24. Jenck F., Ouagazzal A.M., Pauly-Evers M., Moreau J.L. OrphaninFQ: role in behavioral fear responses and vulnerability to stress? Mol. Psychiatry. 5:2000;572-574
25. Jenck F., Wichmann J., Dautzenberg F.M., Moreau J.L., Ouagazzal A.M., Martin J.R., et al. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad. Sci. U. S. A. 97:2000;4938-4943
26. Kaye W.H., Gwirtsman H.E., George D.T., Ebert M., Jimerson D.C., Tomai T.P., et al. Elevated cerebrospinal fluid levels of immunoreactive corticotrophin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function and intensity of depression. J. Clin. Endocrinol. Metab. 64:1987;203-208
27. Kling M.A., Demitrack M.A., Whitfield H.J., Kalogeras K.T., Listwak S.J., DeBellis M.D., et al. Effects of the glucocorticoid antagonist RU 486 on pituitary-adrenal function in patient with anorexia nervosa and healthy volunteers: enhancement of plasma ACTH and cortisol secretion in underweight patients. Neuroendocrinology. 57:1993;1082-1091
28. Koob G.F. Corticotropin-releasing factor, norepinephrine, and stress. Biol. Psychiatry. 46:1999;1167-1180
29. Koob G.F., Heinrichs S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 848:1999;141-152
30. Koster A., Montkowski A., Schulz S., Stube E.M., Knaudt K., Jenck F., et al. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. U. S. A. 96:1999;10444-10449
31. Krahn D.D., Gosnell B.A., Levine A.S., Morley J.E. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res. 443:1988;63-69
32. Le Cudennec C., Naudin B., Do Rego J.C., Costentin J. Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection. Life Sci. 72:2002;163-171
33. Lee Y., Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J. Neurosci. 17:1997;6434-6446
34. Licinio J., Wong M.L., Gold P.W. The hypothalamic-pituitary-adrenal axis in anorexia nervosa. Psychiatry Res. 62:1996;75-83
35. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., DeSouza E.B., et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U. S. A. 92:1995;836-840
36. Makino S., Shibasaki T., Yamauchi N., Nishioka T., Mimoto T., Wakabayashi I., et al. Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat. Brain Res. 850:1999;136-143
37. Martin-Fardon R., Ciccocioppo R., Massi M., Weiss F. Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. NeuroReport. 11:2000;1939-1943
38. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535
39. Neal C.R. Jr., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Akil H., et al. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J. Comp. Neurol. 412:1999;563-605
40. Neal C.R. Jr., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Watson S.J. Jr. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406:1999;503-547
41. Ohata H., Suzuki K., Oki Y., Shibasaki T. Urocortin in the ventromedial hypothalamic nucleus acts as an inhibitor of feeding behavior in rats. Brain Res. 861:2000;1-7
42. Polidori C., Calo' G., Ciccocioppo R., Guerrini R., Regoli D., Massi M. Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology. 148:2000;430-437
43. Polidori C., De Caro G., Massi M. The hyperphagic effect of nociceptin/orphanin FQ in rats. Peptides. 21:2000;1051-1062
44. Pomonis J.D., Billington C.J., Levine A.S., Orphanin F.Q. Agonist of orphan opioid receptor ORL1, stimulates feeding in rats. NeuroReport. 8:1996;369-371
45. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., et al. Orphanin FQ: a neuropeptide that activates an opioid-like G protein- coupled receptor. Science. 270:1995;792-794
46. Richard D., Lin Q., Timofeeva E. The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance. Eur. J. Pharmacol. 440:2002;189-197
47. Risold P.Y., Swanson L.W. Connections of the rat lateral septal complex. Brain Res. Rev. 24:1997;115-195
48. Sarnyai Z., Shaham Y., Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol. Rev. 53:2001;209-243
49. Schweitzer I., Szmukler G.I., Maguire K.P., Harrison L.C., Tuckwell V., Davies B.M. The dexamethasone suppression test in anorexia nervosa. The influence of weight, depression, adrenocorticotrophic hormone and dexamethasone. Br. J. Psychiatry. 157:1990;713-717
50. Sun N., Roberts L., Cassell M.D. Rat central amygdaloid nucleus projections to the bed nucleus of the stria terminalis. Brain Res. Bull. 27:1991;651-662
51. Swanson L.W. Cerebral hemisphere regulation of motivated behavior(1). Brain Res. 886:2000;113-164
52. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 213:1981;1394-1397
53. Valentino R.J., Page M.E., Curtis A.L. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res. 555:1991;25-34